Relationship between vancomycin trough concentration and 24-h area under the curve concentration in Tunisian patients

Sarra MAHFOUDHI; Emna GAIES; CHARFI Rim; Nadia JEBABLI; Mouna BEN SASSI; Hanene EL JEBARI; Daghfous Riadh; Sameh TRABELSI

doi:10.5897/AJPP2022.5336

African Journal of
Pharmacy and Pharmacology

Abbreviation: Afr. J. Pharm. Pharmacol.
Language: English
ISSN: 1996-0816
DOI: 10.5897/AJPP
Start Year: 2007
Published Articles: 2285

Full Length Research Paper

Relationship between vancomycin trough concentration and 24-h area under the curve concentration in Tunisian patients

Sarra MAHFOUDHI

Sarra MAHFOUDHI
Department of Analytical Chemistry (LR12ES09), University of Pharmacy, Road Avicenne 5000, Monastir, Tunisia.
Search for this author on:
Google Scholar

Emna GAIES

Emna GAIES
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

CHARFI Rim

CHARFI Rim
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

Nadia JEBABLI

Nadia JEBABLI
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

Mouna BEN SASSI

Mouna BEN SASSI
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

Hanene EL JEBARI

Hanene EL JEBARI
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

Daghfous Riadh

Daghfous Riadh
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

Sameh TRABELSI

Sameh TRABELSI
Department of Clinical Pharmacology-National Centre “Chalbi Belkahia” of Pharmacovigilance, Tunis, Tunisia.
Search for this author on:
Google Scholar

Article Number - 5C034D770823
Vol.17(5), pp. 85-88 , June 2023
https://doi.org/10.5897/AJPP2022.5336

Received: 09 November 2022
Accepted: 05 June 2023
Published: 30 June 2023

References

Biagi MJ, Butler DA, Wenzler E (2019). AUC-Based Monitoring of Vancomycin: Closing the Therapeutic Window. The Journal of Applied Laboratory Medicine 3(4):743 746. Crossref

Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA(2005). Staphylococcus aureus Endocarditis: A Consequence of Medical Progress. JAMA 293(24):3012. Crossref

Ghosh N, Chavada R, Maley M, van Hal SJ (2014). Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection 20(12):O1098-1105. Crossref

Hale CM, Seabury RW, Steele JM, Darko W, Miller CD (2017). Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection? Journal of Pharmacy Practice 30(3):329?335. Crossref

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ (2011). Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary. Clinical Infectious Diseases 52(3):285?292. Crossref

Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G (2019). Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center. Pharmacotherapy 39(4):433?442. Crossref

Neely MN, Youn G, Jones B, Jelliffe RW, Drusano GL, Rodvold KA, Lodise TP (2014). Are Vancomycin Trough Concentrations Adequate for Optimal Dosing? Antimicrobial Agents and Chemotherapy 58(1):309 316. Crossref

Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM (2004). Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Journal of Clinical Microbiology 42(6):2398 2402. Crossref

Thompson DF, Raebel MA, Freeman CD, Quintiliani R, Nightingale CH. (1993). Vancomycin Therapeutic Drug Monitoring: Is it Necessary? . Annals of Pharmacotherapy 27(5):594-598. Crossref